Ingram Micro reports Q1 2026 results today — and it enters the print with Wall Street playing catch-up after a month in which the stock jumped 36%.
The analyst story this week is unusually active for a tech distributor. Goldman Sachs raised its target to $30 on April 23, keeping a Neutral rating but acknowledging the re-rating. Two days earlier, RBC Capital lifted its target to $33 while maintaining Outperform. The mean analyst target now stands at $27.62 — below where the stock already trades at $30.30. That inversion matters: the consensus is technically pointing to a small drawdown from current levels, and with Goldman marking the upper end of the cautious camp at exactly the current price, the Street has not fully blessed the move higher. RBC's $33 target is the clearest bullish flag, though even that implies only modest further upside. Truist initiated coverage at Hold with a $25 target on March 31, adding another sceptical voice to a cluster of analysts running behind the price action.
Options positioning reflects a market leaning decisively toward calls. The put/call ratio has dropped to 0.04 — near the 52-week low of 0.033 — and well below the 20-day average of 0.067. At nearly one standard deviation below that mean, the options market is showing almost no appetite for downside protection heading into the print. That kind of skew is consistent with a market that has already made up its mind, and it raises the stakes if the result disappoints.
Short interest is modest and unlikely to be the driver either way. It edged up 8.4% over the past week to 1.77% of the free float, a gentle drift higher from the ~1.6% range that held through most of April. Availability remains ample, and borrowing costs are low — just 0.64% annualised — having declined around 24% over the past month from levels closer to 1%. The borrow market is loose by any measure, with the 52-week peak utilisation reading of 37% well above the current 6.4%. None of these signals suggest a crowded short or meaningful squeeze pressure.
The ownership picture carries one headline worth noting. Platinum Equity — which holds 85% of outstanding shares — sold a combined ~13.8 million shares in March at $21.36. That is a substantial disposal, yet it came at a price roughly 30% below where the stock trades today. Whether that reflects opportunistic trimming ahead of anticipated further gains or a read on fair value is the question that institutional buyers will be asking. The broader holder base is building: Capital Research added 540,000 shares in Q1, Goldman Sachs Asset Management added 397,000, and River Road added 620,000. The direction of incremental institutional flow is constructive even as the controlling shareholder reduced.
The earnings history adds important context. The last result, reported in early March 2026, sent the stock up 18% on the day and held most of that gain over the following week. The prior print moved it the other way — down 15.6% on day one and nearly 19% by day five. The pattern is binary: Ingram Micro has delivered large post-earnings moves in both directions in recent quarters. With the stock already up 42% year-to-date and options traders heavily positioned for upside, the asymmetry around today's release is worth watching closely — a beat that merely confirms the re-rating may find it hard to replicate March's reaction, while any miss would meet a market that has priced in considerable optimism.
See the live data behind this article on ORTEX.
Open INGM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
